ADPR-based solutions for specialized environments

The present inventive concept adapts the use of 5′-adenosine diphosphate ribose (ADPR) for treating various diseases and conditions to specific, narrow markets or unique operational environments, such as high-security needs, disaster relief, or extreme weather conditions.

The original patent disclosed methods for using ADPR in various therapeutic applications. However, these methods may not be suitable for specific, high-stakes environments where the risks of infection, disease, or injury are elevated. The present inventive concept addresses this limitation by providing specialized ADPR-based solutions tailored to these unique environments.

The inventive concept comprises a range of ADPR-based pharmaceutical compositions and systems designed for use in high-security environments, disaster relief situations, extreme weather conditions, and resource-limited areas. For example, a portable ADPR-based pharmaceutical composition can be stored in a secure container for treating ophthalmic disorders in high-security environments. In disaster relief situations, an ADPR-based composition can be formulated for oral administration in a compact, waterproof package to prevent adenovirus-related diseases. Topical ADPR-based compositions can be designed with water-resistant film-forming agents and cooling agents to enhance wound healing in extreme weather conditions. Additionally, systems for managing cancer treatment in remote areas can comprise portable ADPR-based pharmaceutical compositions, dosing calculators, and communication devices for remote consultation with healthcare professionals.

The present inventive concept's novelty lies in its adaptation of ADPR-based solutions to specific, high-stakes environments. The inventive step involves the recognition of the need for specialized solutions in these environments and the design of ADPR-based compositions and systems that address these unique challenges.

Other embodiments of the inventive concept could include ADPR-based solutions for treating diseases or conditions caused by physical, chemical, thermal, or radiation injuries in extreme environments. Alternative formulations of ADPR could be developed for use in high-altitude or space environments, where the risks of infection and disease are elevated.

The present inventive concept has significant commercial potential in various industries, including pharmaceuticals, biotechnology, disaster relief, and defense. The target markets include high-security environments, disaster relief organizations, and healthcare providers operating in resource-limited areas.